Breadcrumb Home Articles Search Articles Search Search Search Filter Results Categories Media (39) News (15) Newsletters (17) Topics Reset Search Genetic Testing for Frontotemporal Dementia Dr. Keith Vossel, Neurologist and Director of the Easton Center , was interviewed by DailyMail about frontotemporal dementia. May 22, 2023 1 min read 2023 Faith and Health Luncheon May 18, 2023 1 min read 2023 Krueger Women’s Health Symposium May 15, 2023 1 min read 2023 SoCal Alzheimer's Disease Research Centers (ADRC) Collaborative Conference May 10, 2023 1 min read Donanemab, Eli Lilly’s New Groundbreaking Alzheimer’s Drug Dr. Keith Vossel, Director of the UCLA Easton Center, was interviewed by MarketWatch about Eli Lilly's new Alzheimer’s medication, donanemab. May 03, 2023 1 min read Spring 2023 Newsletter As a risk factor for Alzheimer's disease (AD), the presence of the e4 version of APOE can contribute to a person's risk of developing LOAD but is in... May 01, 2023 1 min read New Study Suggests that a Catheter Ablation for Afib Could Reduce Risk of Cognitive Decline April 20, 2023 1 min read The Uniqueness of Alzheimer's New Medication February 21, 2023 1 min read The Neurodegenerative Disorders Awareness Night at UCLA February 21, 2023 1 min read Winter 2023 Newsletter Investigators announced positive results from a phase 3 study of the amyloid-lowering monoclonal antibody lecanemab.... February 10, 2023 1 min read Pagination Previous page Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Next page
